The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. uri icon

authors

  • Ouk, Michael
  • Lanctôt, Krista L
  • Black, Sandra E
  • Swardfager, Walter
  • Wu, Che-Yuan
  • Rabin, Jennifer S
  • Jackson, Aaron
  • Edwards, Jodi D
  • Ramirez, Joel
  • Masellis, Mario
  • Swartz, Richard H
  • Herrmann, Nathan

publication date

  • January 1, 2021